Pediatrix Medical Group, Inc. with ticker code (MD) have now 9 analysts in total covering the stock. The consensus rating is pointing to ‘Hold’. The target price High/Low ranges between 23 and 14 calculating the mean target price we have $17.17. Given that the stocks previous close was at $13.72 this would imply there is now a potential upside of 25.1%. It’s also worth noting that there is a 50 day moving average of $14.85 and the 200 day MA is $16.84. The company has a market cap of $1,175m. Find out more information at: https://www.pediatrix.com
The potential market cap would be $1,471m based on the market consensus.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 18.49, revenue per share of 23.63 and a 4.93% return on assets.
